Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
---|
02/28/2012 | US8124731 Optimized Fc variants and methods for their generation |
02/28/2012 | US8124729 Splice variants of human G-protein coupled receptor HGPRBMY29 (HGPRMBY29SV2) |
02/28/2012 | US8124727 Use of modified metal oxides for enrichment of phosphopeptides |
02/28/2012 | US8124725 PDGF-Rβ binders |
02/28/2012 | US8124099 Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells |
02/28/2012 | CA2371222C Functionalised solid support for alpha-oxoaldehyde synthesis |
02/23/2012 | WO2012024613A1 Synergistic biomolecule-polymer conjugates |
02/23/2012 | WO2012024452A2 Modified relaxin polypeptides and their uses |
02/23/2012 | US20120046240 Method of Producing Hydroxyalkyl Starch Derivatives |
02/23/2012 | US20120046229 Modified relaxin polypeptides and their uses |
02/23/2012 | US20120045394 Human and mouse targeting peptides identified by phage display |
02/23/2012 | CA2808596A1 Modified relaxin polypeptides and their uses |
02/22/2012 | EP2419452A1 Affinity material |
02/22/2012 | EP1572234B1 STABILIZED IMMUNOGENIC HBc CHIMER PARTICLES |
02/22/2012 | CN101381412B 聚合物/重组人促红素偶联物 Polymer / recombinant human erythropoietin conjugates |
02/21/2012 | US8119590 Apolipoprotein A-I (ApoA-I), preferably a variant form such as Apolipoprotein A-I Milano (ApoA-IM), alone or more preferably in combination with a lipid carrier such as phospholipids or other drug, can be administered locally |
02/21/2012 | US8119359 Methods of indentifying sweet taste modulators |
02/21/2012 | US8119354 Cell-free assay product and method of use thereof for measuring activity of frizzled receptors |
02/16/2012 | WO2012020124A1 Vaccine engineering |
02/16/2012 | US20120039984 Glycopeptide and uses thereof |
02/16/2012 | US20120039924 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease |
02/16/2012 | US20120039916 Novel vaccine adjuvants based on targeting adjuvants to antibodies directly to antigen-presenting cells |
02/16/2012 | US20120039899 Anti-Hemagglutinin Antibody Compositions And Methods Of Use Thereof |
02/16/2012 | DE102007056875B4 Affinitätsstrukturen zur spezifischen Bindung von Substanzen durch nicht-kovalente Interaktionsformen Structures affinity for the specific binding of substances by non-covalent interaction forms |
02/15/2012 | CN101636414B 聚乙二醇修饰的干扰素α2b及其制备方法和应用 Pegylated interferon α2b and its preparation method and application |
02/14/2012 | US8114431 Biomolecular coating for implants |
02/09/2012 | US20120034671 Protein Matrix For Light-Initiated Electron Transfer |
02/09/2012 | US20120034230 Cna-B DOMAIN ANTIGENS IN VACCINES AGAINST GRAM POSITIVE BACTERIA |
02/09/2012 | US20120034168 Isolated Monoclonal Antibody or Fragment Thereof Binding Prostate Specific Membrane Antigen, Conjugates and Uses Thereof |
02/08/2012 | EP2416158A1 Method for detecting substance in biological sample |
02/08/2012 | EP2414400A2 Stabilizing composition for immobilized biomolecules |
02/08/2012 | EP1416972B1 Chimeric molecules to modulate gene expression |
02/08/2012 | CN102348715A Extended recombinant polypeptides and compositions comprising same |
02/07/2012 | US8110661 Anti-IP-10 antibodies and methods of use thereof |
02/07/2012 | US8110660 Soluble ENPP4 protein |
02/07/2012 | US8110654 T cell epitope peptides of ovarian cancer anti-idiotypic antibody 6B11 and use thereof |
02/07/2012 | CA2624175C Cgrp peptide antagonists and conjugates |
02/07/2012 | CA2301964C Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses |
02/02/2012 | WO2011156895A3 Porous magnetic nanoparticles and uses thereof formed by incomplete hydrolysis |
02/02/2012 | US20120028880 Vegfr-1/nrp-1 targeting peptides |
02/02/2012 | US20120027814 Polymeric Fibers Having Tissue Reactive Members |
02/02/2012 | US20120027784 Monomethylvaline compounds capable of conjugation to ligands |
02/02/2012 | US20120027783 Monomethylvaline compounds capable of conjugation to ligands |
02/02/2012 | US20120027782 Monoclonal antibody partner molecule conjugates directed to protein tyrosine kinase 7 (ptk7) |
02/02/2012 | US20120027742 Methods for treating adult respiratory distress syndrome |
02/02/2012 | US20120027720 Peptide conjugates |
02/02/2012 | US20120027679 Contrast agent for photoacoustic imaging and photoacoustic imaging method using the same |
02/02/2012 | US20120027677 Prion-specific peptoid reagents |
02/02/2012 | CA2805902A1 Recombinant lectins, binding-site modified lectins and uses thereof |
02/02/2012 | CA2805743A1 Drug-ligand conjugates, synthesis thereof, and intermediates thereto |
02/02/2012 | CA2805739A1 Drug-ligand conjugates, synthesis thereof, and intermediates thereto |
02/01/2012 | EP2412729A2 Peptide purification by means of hard metal ion affinity chromatography |
02/01/2012 | EP1343801B1 Method for immobilising probes, in particular for producing biochips |
02/01/2012 | CN102341920A Multilayer transparent light-receiving element and electronic device |
02/01/2012 | CN101002943B 支链peg-gcsf和peg-gmcsf结合物及其制备方法 Branched peg-gcsf and peg-gmcsf conjugates and its preparation method |
01/31/2012 | US8106160 N-terminal modified interferon-alpha |
01/31/2012 | US8106159 Insecticidal toxin complex fusion protiens |
01/31/2012 | US8106156 PRO1120 polypeptides |
01/31/2012 | US8106005 Modulating apoptosis |
01/31/2012 | US8105789 Diagnosis and treatment of infectious diseases through indel-differentiated proteins |
01/31/2012 | US8105766 Method of measuring pyrophosphate |
01/26/2012 | WO2012009953A1 Compositions and methods for controlled release of biomolecules |
01/26/2012 | US20120022231 Method for Manufacturing Cubic Diamond Nanocrystals |
01/26/2012 | US20120021063 Crosslinked material comprising elastin and collagen, and use thereof |
01/26/2012 | US20120020986 Antibodies to the PcrV Antigen of Pseudomonas aeruginosa |
01/26/2012 | US20120020893 Intravascular Imaging Device and Uses Thereof |
01/26/2012 | CA2806076A1 Anti-tumor antigen antibodies and methods of use |
01/25/2012 | EP2408821A1 Dynamic bio-nanoparticle elements |
01/25/2012 | EP1019437B1 Method for the covalent attachment of polysaccharides to protein molecules |
01/25/2012 | CN102329395A Method for preparing PEG (Polyethylene Glycol)ylation basic fibroblast growth factor |
01/24/2012 | US8101712 Extracting impurities from broth having echinocandin compound with non polar water-immiscible organic solvent to obtain first two-phase system comprising aqueous phase and organic phase, removing organic phase, extracting echinocandin from aqueous phase with water-immiscible solvent |
01/24/2012 | US8101187 Secreted Streptococcus pneumoniae proteins |
01/24/2012 | CA2462857C Angiotensin peptide-carrier conjugates and uses thereof |
01/24/2012 | CA2295691C Methods and compositions for impairing multiplication of hiv-1 |
01/19/2012 | WO2011109106A3 Immunogenic compositions against human progastrin peptides |
01/19/2012 | US20120016109 Estrogen receptors and methods of use |
01/19/2012 | US20120015432 Isolated bitter taste receptor polypeptides |
01/19/2012 | US20120014975 Modified single domain antigen binding molecules and uses thereof |
01/19/2012 | US20120014972 Influenza virus compositions and methods for universal vaccines |
01/19/2012 | US20120014954 Sparc binding scfvs |
01/19/2012 | US20120014874 Photosensitizer-metal nanoparticle charge complex and composition containing the complex for photodynamic therapy or diagnosis |
01/19/2012 | US20120014873 Peptides whose uptake by cells is controllable |
01/17/2012 | US8097703 CD19 antibodies and their uses |
01/17/2012 | US8097426 Methods of screening T1R2/T1R3 receptors for compounds which modulate sweet taste signaling |
01/17/2012 | US8097421 Method for performing a multiplex immunoassay using label disassociation and an integrated substrate |
01/17/2012 | US8097405 Nucleic acid sequencing processes using non-radioactive detectable modified or labeled nucleotides or nucleotide analogs, and other processes for nucleic acid detection and chromosomal characterization using such non-radioactive detectable modified or labeled nucleotides or nucleotide analogs |
01/12/2012 | WO2012006395A1 Respiratory syncytial virus antigenic compositions and methods |
01/12/2012 | WO2003085121A9 Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer |
01/12/2012 | US20120010147 Nmdar biomarkers for diagnosis and treatment of traumatic brain injury and other disorders |
01/12/2012 | US20120009212 Conjugates utilizing platform technology for stimulating immune response |
01/12/2012 | US20120009205 Modified Fc Molecules |
01/12/2012 | US20120009194 Antibodies to endoplasmin and their use |
01/12/2012 | US20120009123 Albumin binding peptide-mediated disease targeting |
01/12/2012 | CA2799934A1 Respiratory syncytial virus antigenic compositions and methods |
01/11/2012 | EP2403939A1 A diguanylate cyclase, method of producing the same and its use in the manufacture of cyclic-di-gmp and analogues thereof |
01/11/2012 | EP1438586B1 Fret protease assays for clostridial toxins |
01/11/2012 | CN102309765A Long-acting anticoagulant polypeptide including immunoglobulin Fc segments as carriers and preparation method of same |
01/11/2012 | CN101781357B Polypeptide for detecting human cancer cells, and application thereof |
01/10/2012 | US8093365 Biocompatible materials containing stable complexes method of TSG-6 and hyaluronan and method of using same |
01/10/2012 | US8093357 Optimized Fc variants and methods for their generation |